首页> 外文OA文献 >Efficacy of an enterovaccine in recurrent episodes of diarrhea in the dog – a pilot study
【2h】

Efficacy of an enterovaccine in recurrent episodes of diarrhea in the dog – a pilot study

机译:肠炎疫苗对狗腹泻反复发作的疗效–一项初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recurrent episodes of self-limiting diarrhea in the dog, due to sudden dietary changes and to stressful or exciting situations, are conditions sometimes difficult to treat. Colifagina®, a commercially available bacterial enterovaccine, showed, in previous studies performed on experimentally induced colitis in mice, to be able to improve both disease activity index and histological appearance, increase colonic secretion of IgA, and reduce inflammatory chemokine secretion. In the present study Colifagina® was administered to five dogs presenting recurrent episodes of self-limiting diarrhea and to one dog presenting chronic diarrhea. During the follow-up period, almost all patients decreased the number of episodes of abnormal defecation and the fecal score of such episodes improved in five out of six dogs. Even if further studies are needed to understand the exact potential of the compound, in dogs presenting recurrent episodes of self-limiting diarrhea due to sudden dietary changes and/or stressing or exciting situations, Colifagina® seems to be helpful in managing most of these patients.
机译:由于突然的饮食变化以及压力大或令人兴奋的情况,狗中自限性腹泻的反复发作有时是难以治疗的疾病。在以前对小鼠实验性结肠炎进行的研究中,可商购的细菌肠ovaccine表明能够改善疾病活动指数和组织学外观,增加IgA的结肠分泌,并减少炎症性趋化因子的分泌。在本研究中,将Colifagina®给予五只表现出自限性腹泻发作的狗和一只表现出慢性腹泻的狗。在随访期间,几乎所有患者减少了异常排便的次数,并且六只狗中有五只狗的粪便得分有所改善。即使需要进一步研究以了解该化合物的确切潜力,在因饮食突然变化和/或压力大或令人兴奋的情况而出现反复发作的自限性腹泻的狗中,Collifagina®似乎也有助于治疗大多数此类患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号